A Multi-center, Randomized, Controlled Study of the Add-on Effect of Selegiline or Zonisamide to L-dopa/DCI Therapy in Parkinson's Disease (DATSZ-PD Study

Category Primary study
Conference2025 International Congress of Parkinson's Disease and Movement Disorders
Year 2025
This article has no abstract
Epistemonikos ID: 4afac974d57128819e744a05332f9c08c697a25c
First added on: Nov 21, 2025